Rallybio Corporation Postpones Closing of Merger with Avenzo Therapeutics, Inc.
Acquiring Company
Rallybio Corporation
Acquired Company
Avenzo Therapeutics and Duality Biotherapeutics
New HavenBiotechnologyTherapeuticsBiopharmaDescription
Rallybio Corporation announced the postponement of the closing date for its merger with Avenzo Therapeutics, Inc. due to unmet closing conditions related to share listings. Originally anticipated for November 6, 2026, the closing has been delayed as the parties continue to seek necessary approvals. Further updates will be communicated as required by law.
Who to call at Rallybio Corporation, and when
When Rallybio Corporation changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Rallybio Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rallybio Corporation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rallybio Corporation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rallybio Corporation makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Avenzo Therapeutics and Duality Biotherapeutics?
Avenzo Therapeutics and Duality Biotherapeutics was acquired by Rallybio Corporation, based in New Haven. The deal was reported on November 6, 2026. Rallybio Corporation is a clinical-stage biotechnology company focused on translating scientific advances into transformative therapies for patients suffering from rare diseases. Rallybio Corporation is publicly traded (RLYB).
When did Rallybio Corporation acquire Avenzo Therapeutics and Duality Biotherapeutics?
Rallybio Corporation's acquisition of Avenzo Therapeutics and Duality Biotherapeutics was reported on November 6, 2026. Rallybio Corporation announced the postponement of the closing date for its merger with Avenzo Therapeutics, Inc. due to unmet closing conditions related to share listings. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Avenzo Therapeutics and Duality Biotherapeutics do?
Avenzo Therapeutics, Inc. is a clinical-stage biotechnology company developing next-generation oncology therapies. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.